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Abstract
The neural crest is a source to produce multipotent neural crest stem cells that have a poten-
tial to differentiate into diverse cell types. The transcription factor SOX10 is expressed
through early neural crest progenitors and stem cells in vertebrates. Here we report the gen-
eration of SOX10-Nano-lantern (NL) reporter human induced pluripotent stem cells (hiPS)
by using CRISPR/Cas9 systems, that are beneficial to investigate the generation and main-
tenance of neural crest progenitor cells. SOX10-NL positive cells are produced transiently
from hiPS cells by treatment with TGFβ inhibitor SB431542 and GSK3 inhibitor CHIR99021.
We found that all SOX10-NL-positive cells expressed an early neural crest marker NGFR,
however SOX10-NL-positive cells purified from differentiated hiPS cells progressively atten-
uate their NL-expression under proliferation. We therefore attempted to maintain SOX10-
NL-positive cells with additional signaling on the plane and sphere culture conditions. These
SOX10-NL cells provide us to investigate mass culture with neural crest cells for stem cell
research.
Introduction
The neural crest cell is a unique, transient part of ectodermal derivatives in developing verte-
brates and has multi-ability to migrate and differentiate into numerous cells including periph-
eral neurons, glia, craniofacial cartilage, cornea and so on [1]. Initial neural crest cells are
raised at the edge of the neural plate and the non-neural ectoderm. According to the formation
of the neural folds, neural crest cells subsequently occur epithelial mesenchymal transition to
delaminate from dorsal neural tube and migrate through several pathways to reach target tis-
sues and differentiate into various cell types as above [2–4].
It has been identified that a lot of genes, including FGF, WNT and retinoic acid signaling,
are involving to neural crest specification and regulation, especially the transcription factor
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SOX10 is a key regulator for the neural crest cells because it is specifically expressed in initial
neural crest cells and defines the stemness of the neural crest cells [5–7]. SOX10 mutations
have been associated with Waardenburg syndrome and Hirschsprung disease. Their defects
are recapitulated in Sox10 heterozygous mice which are viable however display hypopigmenta-
tion and aganglionic megacolon [8].
In this study, we focused on the purification and the maintenance of neural crest cells dif-
ferentiated from human induced pluripotent stem (hiPS) cells with Nano-lantern (NL) knock-
in reporter, which is a chimeric fluorescent protein of enhanced Renilla luciferase and Venus
[9]. In contrast to the previous SOX10-reporter lines as SOX10 heterozygous or transgenic
cells [8, 10–12], our construct achieved bicistronic expression of NL and targeted SOX10 gene.
We have identified additional proper signaling regulators to maintain SOX10-NL positive
cells, although most of NL intensity are not detectable after in vitro culture for neural crest
cells. SOX10-NL hiPS cells would be used for the research of human neural crest development
and neural crest stem cell.
Materials and Methods
Ethical statement
This study was carried out according to the regulations of Kyoto Prefectural University of
Medicine. The experimental protocols dealing with human subjects were approved by the Eth-
ics committee and the Gene Recombination Experiment Safety Committee of Kyoto Prefec-
tural University of Medicine (permit number: 26–5). Written informed consent was provided
by each donor.
Gene targeting with human iPS cells
To construct a human SOX10 targeting vector, we inserted 2A-Nano-lantern (NL) [9,13] and
loxP-pGK-Neo-loxP (floxedNeo) cassette after the stop codon located on exon4 of hSOX10 to
cause bicistronic expressions of hSOX10 and NL (S1 Fig panel A). The sequence of 2A peptide
was produced by synthesized oligos and NL fragments was amplified by PCR with KOD-Plus-
Neo polymerase (TOYOBO) and pcDNA3-Nano-lantern (Addgene #51970) to construct pBS-
2A-NL-pA. The fragment of floxedNeo was amplified by PCR from pBS-floxedNeo vector
[14]. Both of 2A-NL-pA and floxedNeo fragments were ligated into pUC19 vector with In-
Fusion HD Cloning Kit (Takara) by manufacture’s protocol (S1 Fig panel B).
For 5’ and 3’ arm of hSOX10 genomic sequences, they are amplified by PCR with genome
DNA extracted from 201B7 hiPS cells [15]. These three fragments, 2A-NL-floxedNeo (2A-NL-
fNeo), 5’of hSOX10, and 3’ of hSOX10 were connected with In-Fusion HD Cloning Kit into
pDT-A vector (pDT-A-hSOX10arm-2A-NL-fNeo, S1 Fig panel C) [16]. All PCR primers are
listed in S1 Table.
To introduce into cultured cells with hSOX10-targeting plasmid vectors,
pX330-hSOX10ex4, which was constructed with pX330 vector (Addgene #42230) [17] by ligat-
ing oligos into it, and linearized pDT-A-hSOX10arm-2A-NL-fNeo, the electroporator NEPA21
(NEPAGENE) was used for introducing plasmid DNAs into hiPS cells as described [18].
Cell culture and neural crest differentiation
hiPS cells were maintained on SNL feeder cells, treated with 10 mg/ml of mitomycin (Sigma)
in DMEM supplemented with 10% of fetal bovine serum (GIBCO), in Primate ES cell medium
(ReproCELL) supplemented with 4 ng/ml recombinant human FGF2 (WAKO) or 100 μg/ml
G418 (Nacalai Tesque). Generated SOX10-NL iPS cells were maintained on iMatrix-511
SOX10-NL hiPS Cells
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(Nippi) coated plates with StemFit AK03N (Ajinomoto) as described under feeder-free culture
system [19].
For neural crest induction, Fukuta et al. showed the detailed protocol to induce neural crest
cells with hiPS cells [20]. In brief, single SOX10-NL iPS cell was expanded in mTeSR1 medium
(STEMCELL Technology) for a few days, and induced into neural crest cells in IMDM and F-
12 medium supplemented with chemically defined lipid concentrate (GIBCO), 1% of BSA
(WAKO), Insulin-Transferrin-Selenium (GIBCO), and 1-thioglycerol (Sigma). Cultured plates
were coated with Geltrex Matrix (GIBCO) or fibronectin (Millipore). SB431542 (Stemgent),
CHIR99021 (Stemgent), EGF (WAKO), FGF2 (WAKO) were used for the induction and
maintenance of neural crest cells. Embryoid bodies were formed as described to determine the
differentiation ability of SOX10-NL hiPS cells [15].
Collected NL-positive neural crest cells were transferred onto fibronectin-coated dishes or
Ultra-Low attachment 96well plates (Corning) for sphere formation with neural crest induc-
tion medium as describes in the result section.
Cell sorting
Cultured cells were dissociated with TrypLE select (GIBCO) at 37˚C for 5 min for detecting
SOX10-NL expression. They were incubated sequentially with antibody against human CD271
(NGFR, p75NTR) conjugates with Alexa647 (BD; diluted 1/100) for 30 min on ice [21]. Disso-
ciated cells were resuspended with 1% bovine serum albumin in PBS. Cell debris was elimi-
nated with a cell strainer (BD; 35 μm) and suspensions were stained with SYTOX Red stain
(Molecular Probes) to exclude dead cells. Cells were analyzed and collected by cell sorter using
FACSJazz (BD).
Time-lapse imaging analyses
SOX10-NL positive (and NGFR-positive) and SOX10-NL negative (and NGFR-negative) cells
were sorted and seeded onto fibronectin-coated tissue culture dishes for 24 hours. After cells
were attached, time-lapse phase contrast images (magnification 10x, 5x5 tiles) were taken at 10
min intervals for 24 hours using BioStation CT (Nikon) at 37˚C with 5% CO2. Cell migration
rate was measured by tracking analysis using CL-Quant software (Nikon) for initial 12 hours
with time-lapse images.
Quantitative PCR analyses
Total RNAs from sorted or cultured cells were extracted using RNeasy micro kit (QIAGEN)
and genome DNAs were extracted by PureLink Genomic DNA kits (Invitrogen). For quantita-
tive PCR analyses, single strand cDNA was prepared using SuperScript VILO kit (Invitrogen)
as manufacture protocol. All RT-qPCR reactions were carried out in triplicate using THUN-
DERBIRD SYBR qPCR Mix (TOYOBO), normalized to mRNA level of ribosomal protein
L13A (RPL13A) or genome DNA expression level of GAPDH as a control [22]. Primers
sequences (5’ to 3’) are listed in S2 Table.
Immunofluorescence assay
Cultured cells were fixed in 4% paraformaldehyde for 10 min at 4˚C, permeabilized with 0.2%
Triton and 50 mM NH4Cl. Fixed samples were pre-treated with BlockingOne (Nacalai Tesque)
for 30 min at RT, and incubated with anti-OCT3/4, anti-NANOG, anti-SSEA4, anti-TRA1-60
(Cell Signaling Technology; diluted 1/200), anti-GFP (Molecular Probes; diluted 1/500), anti-
SOX10 (SantaCruz Biotechnology; diluted 1/100) antibodies in 5% of BlockingOne in PBST
SOX10-NL hiPS Cells
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for overnight at 4˚C. After three washes with 0.1% Tween20 in PBS, cells were incubated with
Alexa488 or Alexa594-conjugated secondary antibodies (Molecular Probes; diluted 1/500).
Cells were washed and mounted in SlowFade Diamond antifade mountant with DAPI (Molec-
ular Probes). Fluorescent images were collected on the software of BZ-X700 (Keyence). For
quantitation of cultured cells, numbers of dishes were analyzed from triplicate experiments.
Results
Human SOX10 genomic DNA digestion with CRISPR/Cas9 system
To cause double strand break to the border between CDS and 3’UTR in hSOX10 exon4 (Fig
1A), a Candidate sequence of the guide RNA (cactgtcccggccctaaagg-gGG, hSOX10ex4) to tar-
get by Cas9 was selected by CRISPRdirect website (http://crispr.dbcls.jp) [23], and inserted
into pX330 vector to create pX330-hSOX10ex4 editing vector (Fig 1B). The effect of double
strand break into hSOX10 genomic sequence of hiPS cells was evaluated by the digestion of
heteroduplex PCR products, involving the target region by pX330-hSOX10ex4 editing vector
monitored with T7 endonuclease I (T7EI). Digested bands of 700 bp and 300 bp were found in
T7EI-treated genome DNA samples, according to treated periods (Fig 1C). The data suggested
that Cas9 and the guide-RNA expressing construct has an efficiency to target hSOX10 genomic
sequence.
Generation of SOX10-NL hiPS reporter line
In order to construct the targeting vector for human SOX10 as designed in S1 Fig, the targeting
sequences along with 5’ and 3’ homology arms (0.7 kbp and 1.0 kbp, respectively) were ampli-
fied by PCR and combined with 2A-NL-floxedNeo reporter sequence by In-Fusion technology
efficiently into pDT-A-hSOX10arm-2A-NL-fNeo vector (Fig 2A, knock-in cassette).
hiPS cells were electroporated with pDT-A-hSOX10arm-2A-NL-fNeo targeting vector and
pX330-hSOX10ex4 editing vector. The electroporated cells were plated on SNL feeder cells,
and G418 selection was started two days later for a week. Single colonies were picked up,
expanded and subsequently genomic DNA was used for screening the correct insertion of
knock-in reporter cassette. PCR results showed that selected clone contained reporter cassette
(Fig 2B, F1+R1, F2+R2). And this clone has been confirmed to obtain one copy of the targeted
Neomycin resistance gene allele by comparing with known knock-in hiPS cell (Fig 2C,
hSOX102A-NL-fNeo/+). To excise the Neomycin resistance gene cassette from hSOX102A-NL-fNeo/+
hiPS cells, pCAG-Cre vector was transiently transfected [24], and single hiPS colonies were
picked up and confirmed the lack of floxed Neo sequence by PCR (Fig 2D, hSOX102A-NL/+).
The selected hiPS clone hSOX102A-NL/+ was confirmed to express pluripotency markers
with OCT3/4, NANOG, SSEA4 and TRA-1-60, after gene targeting and antibiotic selection
experiments (Fig 2E). This clone also had the multipotency to differentiate into ectodermal
(PAX6), mesodermal (T), and endodermal (FOXA2) cells in embryoid bodies (Fig 2F). This
clone was therefore chosen for the induction experiments to neural crest cells.
Confirmation of SOX10-NL activity during neural crest differentiation
hiPS SOX102A-NL/+ reporter cells were differentiated into the neural crest lineage using the pro-
tocol as described [20], with SB431542, a specific inhibitor of TGFß receptor kinase, and
CHIR99021, an inhibitor of GSK3 to function as a WNT activator, for nine days (Fig 3A–3D),
and NL activity and SOX10 expression were analyzed during the differentiated periods. Analy-
ses of Fluorescence activated cell sorting (FACS) and luciferase activity showed NL reporter
activity started to increase about day 5 of differentiation and around 20% of NL positive (NL+)
SOX10-NL hiPS Cells
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Fig 1. Effect of guide sequence to human SOX10 on Cas9 activity. (A) A model of Cas9 activity to the
human SOX10 exon4 locus. (B) Cas9 with matching single guide RNA (sgRNA, red) and proto-spacer
adaptor motif (PAM, blue) sequences adjacent to human SOX10 stop codon. (C) T7 endonuclease 1 assay
for Cas9-mediated cleavage (700bp and 300bp) on the gel showing comparable modification of targeted
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Fig 2. Generation of hSOX10-2A-Nano-lantern reporter hiPS cells. (A) A schematic representation of
targeting cassette for hSOX102A-NL-fNeo/+ or hSOX102A-NL/+ knockin allele. (B) Genotyping PCR with genome
DNA extracted from hiPS 201B7 and hSOX102A-NL-fNeo/+ hiPS cells. Genomic recombined 5’fragment of targeting
cassette was detectable by F1 and R1 primers, and also 3’ fragment by F2 and R2 primers. (C) DNA Copy
number check by quantitative PCR with genome DNA extracted from hiPS 201B7, Pax3EGFP-fNeo/+, and
SOX10-NL hiPS Cells
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cells were detected at day 9 of differentiation (Fig 3E, and S2 Fig). These differentiated cells at
day 7 were fixed and stained with anti-SOX10 antibody to confirm co-expression of NL and
SOX10. As expected, NL+ cells co-express SOX10, indicating that NL-reporter cassette mimics
the activation of endogenous SOX10 expression (Fig 3F–3I). We also confirmed the co-expres-
sion by detecting enriched SOX10 transcripts in NL+ sorted cells (Fig 3J). In order to expand
NL+ sorted cells, NL+ cells were grown in described culture media supplemented with
10 ng/mL of FGF2 and 10 ng/mL of EGF on fibronectin-coated plates16. NL fluorescent
expression could be detected in NL+ sorted cells cultured for 24 hours under microscopy,
however their NL intensity was attenuated in cultured cells for 48 hours (Fig 3K–3N).
Characteristics of SOX10-NL+ neural crest cells
SOX10-NL+ cells were purified by FACS as neural crest cells differentiated from hiPS cells. The
SOX10-NL+ population isolated from differentiated neural crest cells for day 6 to day 11 exhib-
ited all co-expression with NGFR (Fig 4A), indicating that NL+ population was identified with
neural crest marker NGFR. However the activity of NL was not detectable in all NGFR+ popula-
tion (Fig 4A). To assess the identity of the NGFR+; NL+ or NGFR+; NL-negative (NGFR+NL-)
cells, we investigated their differences. Same numbers of NGFR+NL+ or NGFR+NL- sorted
cells were seeded on fibronectin-coated dishes and expanded for a week. Almost cultured cells
were detected with NGFR+ in both conditions (Fig 4B–4E), however the percentage of NL+ was
decreased in this culture condition as shown in Fig 3 (Fig 4E). And this NL+ proportion was
declined according to passage numbers (Fig 4F). The cell numbers after expansion of NL+ cells
showed much higher than those of NGFR+NL- cells, indicating that NL+ neural crest cells
have a competent to be propagated than NGFR+ neural crest cells (Fig 4G).
Effects of pivotal exogenous factors to maintain SOX10-NL positive
neural crest cells
SOX10-NL+ cells had a differentiation potential into cells of peripheral nervous system, and
mesenchymal stem cells (S3 Fig), and an ability of cell migration (S4 Fig and S1 Movie), how-
ever these cells do not remain the activity of NL but rather spontaneously differentiate into
NGFR+NL- cells in culture medium containing SB431542, FGF2 and EGF. We therefore
sought the appropriated condition to expand cells keeping the NL activity. Subsequent screen-
ing of inhibitors and growth factors revealed that SB431542 was essential for the increase of
the ratio of NL+ cells (Fig 5A). CHIR99021 also had the effect to NL+ cell positively, however
high dose of this inhibitor (higher than 5 μM) conversely down-regulated the ratio of NL+ cells
(Fig 5B). As shown in Fig 5A, we found that FGF2 might have the negative effect to NL+ activ-
ity although cultured cells supplemented with 10 ng/mL of FGF2 were grown well and healthy
because of few dead cells, which were stained with SYTOX red (not shown). However high
doses of FGF2, more than 500 pg/mL drastically reduced the NL activity, and the proportion
of NL+ in NL+ cultured cells was gradually diminished by the amount of FGF2 (Fig 5C).
Kerosuo et al. recently indicated epithelial sphere culture of premigratory neural crest cells
to maintain their self-renewing and multipotent state [25]. We tested to determine optimal
hSOX102A-NL-fNeo/+ cells. All error bars indicate ±s.e.m. (n = 3) (D) The excision of loxP-Neo-loxP genomic
fragment in hSOX102A-NL-fNeo/+ hiPS cells with Cre recombinase treatment to establish hSOX102A-NL/+ hiPS cells.
(E) hSOX102A-NL-fNeo/+ cells were immunostained with indicated undifferentiated pluripotent cell markers, anti-
OCT3/4 (red, upper panel) and anti-SSEA4 (green, upper panel), anti-NANOG (red, lower panel) and anti-TRA1-
60 (green, lower panel) antibodies. Nuclei were stained with 4’6-diamidino-2-phenylindole (DAPI, blue). Scale bar,
100 μm. (F) Differentiation capacity into ectoderm (PAX6), mesoderm (T), endoderm (FOXA2) markers with
embryonic bodies (EB day7) from hSOX102A-NL/+cells.
doi:10.1371/journal.pone.0170342.g002
SOX10-NL hiPS Cells
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Fig 3. Induction of Nano-lantern-positive cells from hSOX102A-NL/+ hiPS cells. (A-D) Morphology of cultured cells from hSOX102A-NL/+
hiPS cells during 3 days (Day3) to 9 days (Day9). Scale bar, 100 μm. (E) FACs profiles for detecting Nano-lantern-positive cells from induced
cells. (F-I) cultured cells for 7 days were immunostained with anti-GFP (Nano-lantern; G, green) and anti-SOX10 (H, red) antibodies. Nuclei
were stained with 4’6-diamidino-2-phenylindole (DAPI, blue). Scale bar, 200 μm. (J) Relative expressions of Nano-lantern and hSOX10 with
Nano-lantern-positive (NL+) or negative (NL-) cells by FACs analyses. All error bars indicate ±s.e.m. (n = 3) (K-N) Cultured Nano-lantern-
positive cells decrease the fluorescent intensity of Nano-lantern expression after 24 hours (K, L) to 48 hours (M, N). Scale bar, 50 μm.
doi:10.1371/journal.pone.0170342.g003
SOX10-NL hiPS Cells
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conditions for enabling SOX10-NL+ cells to aggregate. Spheres with NL+ cells were succes-
sively formed in the same condition of monolayer culture of NL+ cells, with 10 μM SB431542
and 1 μM CHIR99021 (Fig 5D). Furthermore, the proportion of NL+ cells in sphere culture
condition was significantly reduced without SB431542 or CHIR99021, or with FGF2 (Fig 5E),
compatible with the monolayer culture (Fig 5A). These data suggested that these pivotal factors
in TGFß, WNT and FGF signaling are effective for the maintenance of NL positively regardless
of cell-cell interaction.
Discussion
Here we present successful generation of SOX10-NL knock-in hiPS cells by the CRISPR/Cas9
and In-Fusion technologies, which are valuable to monitor SOX10 expression by both of fluo-
rescent and luciferase activities. Nano-lantern enable us to perform not only real-time imaging
in living cells as other fluorescent proteins, but also in vivo imaging by sensitive luminescent
detection. This SOX10-NL hiPS cell lines can be also used for evaluation of directed differenti-
ation toward neural crest lineage using chemical screening as well as to study temporal
Fig 4. Characteristics of Nano-lantern-positive neural crest cells. (A) Flow cytometry plots of induced Nano-lantern-positive cells from
hSOX102A-NL/+ hiPS cells for 6 days (day 6) or 11 days (day 11). All Nano-lantern-positive cells indicate in NGFR (p75)-positive fraction. (B-E) FACs-
purified cells (NGFR+NL-; B, C or NGFR+NL+; D, E) were cultured for 7 days and immunostainted with anti-NGFR (red in C, E) and anti-GFP (Nano-
lantern; green in C, E) antibodies. Nuclei were stained with 4’6-diamidino-2-phenylindole (DAPI, blue). Scale bar, 100 μm (F) Continuously decreased
Nano-lantern-positive percentages in Nano-lantern-positively sorted and cultured cells. (G) Nano-lantern-positive cells (NGFR+NL+) grow faster than
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emergence of neural crest stem cells during in vitro differentiation. Moreover, our approach
shown here is simple, efficient and versatile to be applicable to generate other reporter knock-
in cells, and ideal gene targeting for predominant genotype like SOX10 because Haploinsuffi-
ciency of hetelozygous SOX10 causes pigmentation and megacolon defect in Hirschsprung dis-
ease [8]. Therefore, we chose not to generate SOX10 heterozygotes or BAC transgenic cells,
which might affect to intact SOX10 or other gene expression, but to target 3’UTR sequence of
SOX10 just with sequences of 2A signal peptide and Nano-lantern instead of SOX10 stop
codon to function intact SOX10 coding sequence.
Although a variety of neural crest-derived cells, differentiated from the pluripotent stem
cells have been used for each experiment, it has difficulty to maintain premigratory embryonic






























Fig 5. effects of exogenous factors to SOX10-Nano-lantern positive cells. (A) The combination effect of SB431542 and CHIR99021 inhibitors,
FGF2, and EGF to cultured Nano-lantern-positive cells. (B) Different CHIR99021 concentrations for the expansion of Nano-lantern-positive cells.
Cultured Nano-lantern-positive cells were analyzed by FACs with or without CHIR99021 (right panels). (C) Effects of FGF2 for the expansion of
Nano-lantern-positive cells. total cultured cells were counted and the percentage of Nano-lantern-positive cells were analyzed. (D) 7 days cultured
images of aggregated spheres derived from Nano-lantern+ cells (below; NL fluorescence image) (E) Effects to NL+ proportion in aggregated
spheres without SB431542 and CHIR99021, or with FGF2. All error bars indicate ±s.e.m. (n = 3). P values are determined by t-test from a two-
tailed distribution. *P<0.05; **P<0.01.
doi:10.1371/journal.pone.0170342.g005
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differentiation in vitro. We found that it was possible to induce SOX10-positive neural crest
cells derived from hiPS cells as shown induction method before [20], although these cells were
immediately differentiated into the NGFR-positive but SOX10-negative population because of
additional FGF signaling, which support their growth. So we identified the necessity of the
inhibition of TGFß, and the appropriate concentration of CHIR99021 and FGF2 for maintain-
ing SOX10-NL activity in vitro culture. And this condition for SOX10-maintaining cell culture
system also adapted to neural crest-sphere culture as well.
Taken together, these results demonstrate that SOX10-expressing cells have self-renewal
capacity and a possibility to form neural crest derivatives under proper differentiated condi-
tions, and provide mass culture method of neural crest cells and would promote the research
to use derivatives from human neural crest cells for cell therapy or drug screenings.
Supporting Information
S1 Fig. General strategy of 2A-Nano-lantern (NL) targeting into the human SOX10 allele.
(A) Schematic diagram of the human SOX10 locus on chromosome 22 and targeting cassette
for SOX10-2A-NL-floxed Neo (hSOX102A-NL-fNeo/+) or SOX10-2A-NL (hSOX102A-NL/+)
knockin allele with genomic double strand break caused by CRISPR/Cas9 system. (B) PCR-
amplified 2A-NL and loxP-pGK-Neo-loxP fragments were recombined with In-fusion clonase
into pUC19 vector (pUC19-2A-NLpA-floxedNeo). (C) Triple DNA fragments (hSOX10 5’arm,
hSOX10 3’arm and 2A-NL-floxedNeo) were recombined with In-fusion clonase into pDT-A
vector for targeting into the human SOX10 allele.
(PDF)
S2 Fig. Luciferase activities of Nano-lantern with induced neural crest cells from hSOX102-
A-NL/+ hiPS cells. Collected cells were counted and analyzed with Renilla Luciferase Assay Sys-
tem (Promega) as manufacturing protocol.
(PDF)
S3 Fig. Induced cells of the peripheral nervous system (PNS) and mesenchymal stem cells
differentiated from SOX10-Nano-lantern positive neural crest cells. (A) NL+ cells were dif-
ferentiated for 14 days supplemented with N2 supplement (GIBCO), 10 ng/mL of BDNF,
GDNF, NT-3 and NGF (WAKO). Differentiated cells were immunostained with anti-ß3-tubu-
lin (right panel). Nuclei were stained with 40,6-diamidino-2-phenylindole (DAPI, middle
panel). Scale bar, 100 μm. (B) Expression of cell surface markers in mesenchymal stem cells.
(PDF)
S4 Fig. SOX10-Nano-lantern positive cells migrate to appropriate chemoattractants. (A)
Representative migrated images from the colony of confluent SOX10-NL+ cells after 36 hours
with or without chemoattractants. (B) NL+ cells migrated to chemoattractants with BMP2,
FGF8 and SDF1. (C) Sorted NL+NGFR+ cells displayed higher migration rate than
NL-NGFR- cells as shown in S1 Movie. P<0.05, P<0.01.
(PDF)
S1 Movie. Movie data for tracking analysis of SOX10-Nano-lantern positive cells.
SOX10-NL+NGFR+ cells (left panel) and SOX10-NL-NGFR- cells (right panel).
(WMV)
S1 Table. primer sequences for SOX10-2A-Nanolantern targeting vector.
(PDF)
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S2 Table. Primer sequences for RT-PCR or genomic PCR used in this study.
(PDF)
Acknowledgments
We are grateful to Dr. Akira Takai (RIKEN QBiC) for detecting Nano-lantern expression,
Nikon cooperation for movie data.
Author Contributions
Conceptualization: TS.
Formal analysis: TH HO TS.
Funding acquisition: MI MU TS.
Investigation: TH HO MS TS.
Methodology: TH HO TS.
Project administration: TS.
Supervision: CS SK TS.
Validation: TH TS.
Writing – original draft: MI TS.
Writing – review & editing: TH TS.
References
1. Le Douarin NM, Kalcheim C. The Neural Crest. Cambridge ( Cambridge University Press) 1999.
2. Anderson DJ. Cellular and molecular biology of neural crest cell lineage determination. Trends Genet.
1997; 13: 276–280. PMID: 9242050
3. Sauka-Spengler T, Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation.
Nat Rev Mol Cell Biol. 2008; 9: 557–568. doi: 10.1038/nrm2428 PMID: 18523435
4. Mayor R, Theveneau E. The neural crest. Development 2013; 140: 2247–2251. doi: 10.1242/dev.
091751 PMID: 23674598
5. Honore´ SM, Aybar MJ, Mayor R. Sox10 is required for the early development of the prospective neural
crest in Xenopus embryos. Dev. Biol. 2003; 260: 79–96. PMID: 12885557
6. Kim J, Lo L, Dormand E, Anderson DJ. SOX10 maintains multipotency and inhibits neuronal differentia-
tion of neural crest stem cells. Neuron 2003; 38: 17–31. PMID: 12691661
7. Kelsh RN. Sorting out Sox10 functions in neural crest development. BioEssays 2006
8. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, et al. The transcription factor
Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001; 15: 66–78. doi: 10.1101/
gad.186601 PMID: 11156606
9. Saito K, Chang YF, Horikawa K, Hatsugai N, Higuchi Y, Hashida M, et al. Luminescent proteins for
high-speed single-cell and whole-body imaging. Nat Commun. 2012; 3: 1262. doi: 10.1038/
ncomms2248 PMID: 23232392
10. Kawaguchi J, Nichols J, Gierl MS, Faial T, Smith A. Isolation and propagation of enteric neural crest pro-
genitor cells from mouse embryonic stem cells and embryos. Development 2010; 137: 693–704. doi:
10.1242/dev.046896 PMID: 20147374
11. Corpening JC, Deal KK, Cantrell VA, Skelton SB, Buehler DP, Southard-Smith EM. Isolation and Live
Imaging of Enteric Progenitors Based on Sox10-Histone2BVenus Transgene Expression. Genesis
2011; 49: 599–618. doi: 10.1002/dvg.20748 PMID: 21504042
12. Chambers SM, Qi Y, Mica Y, Lee G, Zhang XJ, Niu L, et al. Combined small-molecule inhibition acceler-
ates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol.
2012; 30: 715–720. doi: 10.1038/nbt.2249 PMID: 22750882
SOX10-NL hiPS Cells
PLOS ONE | DOI:10.1371/journal.pone.0170342 January 20, 2017 12 / 13
13. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, et al. Correction of multi-gene
deficiency in vivo using a single ’self-cleaving’ 2A peptide-based retroviral vector. Nat Biotechnol. 2004;
22: 589–594. doi: 10.1038/nbt957 PMID: 15064769
14. Hiramuki Y, Sato T, Furuta Y, Surani MA, Sehara-Fujisawa A. Mest but Not MiR-335 Affects Skeletal
Muscle Growth and Regeneration. PLoS One 2015; 10: e0130436. doi: 10.1371/journal.pone.0130436
PMID: 26098312
15. Takahashi K. Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872. doi: 10.1016/j.cell.
2007.11.019 PMID: 18035408
16. Ikeya M, Kawada M, Nakazawa Y, Sakuragi M, Sasai N, Ueno M, et al. Gene disruption/knock-in analy-
sis of mONT3: vector construction by employing both in vivo and in vitro recombinations. Int J Dev Biol.
2005; 49: 807–823. doi: 10.1387/ijdb.051975mi PMID: 16172977
17. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-
Cas9 system. Nat Protoc. 2013; 8: 2281–2308. doi: 10.1038/nprot.2013.143 PMID: 24157548
18. Li HL. Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, et al. Precise correction of the dystro-
phin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and
CRISPR-Cas9. Stem Cell Rep. 2015; 4: 143–154.
19. Nakagawa M. Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, et al. A novel efficient feeder-
free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 2014; 4: 3594.
doi: 10.1038/srep03594 PMID: 24399248
20. Fukuta M, Nakai Y, Kirino K, Nakagawa M, Sekiguchi K, Nagata S, et al. Derivation of Mesenchymal
Stromal Cells from Pluripotent Stem Cells through a Neural Crest Lineage using Small Molecule Com-
pounds with Defined Media. PLoS One 2014; 9: e112291. doi: 10.1371/journal.pone.0112291 PMID:
25464501
21. Lee G, Kim H, Elkabetz Y, Al Shamy G, Panagiotakos G, Barberi T, et al. Isolation and directed differen-
tiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol. 2007; 25:
1468–1475. doi: 10.1038/nbt1365 PMID: 18037878
22. Sato T, Yamamoto T, Sehara-Fujisawa A. miR-195/497 induce postnatal quiescence of skeletal muscle
stem cells. Nat. Commun. 2014; 5: 4597. doi: 10.1038/ncomms5597 PMID: 25119651
23. Naito Y, Hino K, Bono H, Ui-Tei K. CRISPRdirect: software for designing CRISPR/Cas guide RNA with
reduced off-target sites. Bioinformatics 2015; 31: 1120–1123. doi: 10.1093/bioinformatics/btu743
PMID: 25414360
24. Sakai K, Miyazaki J. A transgenic mouse line that retains Cre recombinase activity in mature oocytes
irrespective of the cre transgene transmission. Biochem Biophys Res Commun. 1997; 237: 318–24.
PMID: 9268708
25. Kerosuo L, Nie S, Bajpai R, Bronner ME. Crestospheres: Long-Term Maintenance of Multipotent, Pre-
migratory Neural Crest Stem Cells. Stem Cell Rep. 2015; 5: 499–507.
SOX10-NL hiPS Cells
PLOS ONE | DOI:10.1371/journal.pone.0170342 January 20, 2017 13 / 13
